CDER Meetings, Conferences & Workshops: August – September 2019

August 2019

• FDA-BCAN Workshop: Endpoints for the Development of Neoadjuvant Systemic Therapy Regimens for Muscle-Invasive Bladder Cancer (MIBC); Aug. 8, 2019, Washington, DC; Live webcast available.
• Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients; Aug. 8, 2019; FDA White Oak Campus – Silver Spring MD; Live webcast available.
• Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real-World Setting Meeting Information; Aug. 12, 2019; FDA White Oak Campus – Silver Spring MD.

September 2019

• SBIA Regulatory Education for Industry (REdI) and CERSI Workshop: Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls; Sep. 23-25, 2019, College Park, MD.
• SBIA RedI 2019 Complex Generic Drug Product Development Workshop – Sep. 25-26, 2019; College Park, MD; Live webcast available.